A4809812
Harmaline , >98.0%(HPLC) , 304-21-2
Synonym(s):
1-Methyl-7-methoxy-3,4-dihydro-β-carboline;3,4-Dihydroharmine;4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole;Dihydroharmine;Harmalol methyl ether
CAS NO.:304-21-2
Empirical Formula: C13H14N2O
Molecular Weight: 214.26
MDL number: MFCD00004955
EINECS: 206-152-6
Pack Size | Price | Stock | Quantity |
25MG | RMB31.20 | In Stock |
|
100mg | RMB79.20 | In Stock |
|
250MG | RMB145.60 | In Stock |
|
1G | RMB479.20 | In Stock |
|
5G | RMB1439.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 232-234 °C(lit.) |
Boiling point: | 354.4°C (rough estimate) |
alpha | ±0° |
Density | 1.0850 (rough estimate) |
refractive index | 1.6450 (estimate) |
Water Solubility | Slightly soluble in water |
solubility | DMF: 1.4 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 0.25 mg/ml; Ethanol: 0.5 mg/ml |
form | powder |
pka | 4.2(at 25℃) |
color | Light orange to Yellow to Green |
Merck | 14,4613 |
BRN | 207310 |
LogP | 2.251 (est) |
Description and Uses
CNS stimulant; may act through NMDA receptors. Reversible inhibitor of MAO-A
Safety
Symbol(GHS) | GHS07,GHS08 |
Signal word | Warning |
Hazard statements | H302-H371 |
Precautionary statements | P260-P264-P270-P301+P312-P308+P311-P405 |
Hazard Codes | Xn |
Risk Statements | 25-20/21/22 |
Safety Statements | 22-24/25-36 |
RIDADR | 1544 |
WGK Germany | 3 |
RTECS | UU9800000 |
HS Code | 2939.80.0000 |
HazardClass | 6.1(b) |
PackingGroup | III |